Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources

ESMO Congress 2019

27 Sep - 01 Oct 2019

Barcelona, Spain

ESMO 2019 1000x1000

Presentations (slides) and webcasts are available to ESMO members according to the presenters' agreement to release them. Abstracts are open access. 

The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Next/upcoming meetings
Translating science into better cancer patient care​

ESMO Videos:   Highlight series | Expert Reports series

Special Sessions and Tracks

More Resources

Hide
Filter by:
Search:
Reset

There are 2934 resources available

Metastatic gastro-oesophageal adenocarcinoma

Presenter: Salah-Eddin Al-Batran

Session: ESMO Colloquium supported by Lilly Oncology - Metastatic gastro-intestinal cancer: Multiple treatment lines, extended pipeline of available drugs and use of predictive markers. How to best sequence the treatment proposal?

Resources:

Slides

Webcast

Metastatic colorectal cancer

Presenter: Michel Ducreux

Session: ESMO Colloquium supported by Lilly Oncology - Metastatic gastro-intestinal cancer: Multiple treatment lines, extended pipeline of available drugs and use of predictive markers. How to best sequence the treatment proposal?

Resources:

Slides

Webcast

Unresectable or relapsed hepato-cellular carcinomas

Presenter: Jean-Luc Raoul

Session: ESMO Colloquium supported by Lilly Oncology - Metastatic gastro-intestinal cancer: Multiple treatment lines, extended pipeline of available drugs and use of predictive markers. How to best sequence the treatment proposal?

Resources:

Slides

Webcast

Are FLT3 Mutated AML a special entity?

Presenter: Gert Ossenkoppele

Session: ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML)

Resources:

Slides

Webcast

Introduction

Presenter: Bernard Escudier

Session: ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting?

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.